Dr Lal Pathlabs Ltd Share Price (LALPATHLAB)
₹2244.6
Dr Lal Pathlabs Ltd share Performance
- ₹2235₹2327₹2244.6
0.43%
Low
Day's Volatility:4.10%
High
3.67%
- ₹1872.55₹2767.1₹2244.6
16.58%
Low
52 Weeks Volatility:39.85%
High
23.28%
| Returns % | |
| 1 Month Return | 15.71 % |
| 3 Month Return | -5.23 % |
| 1 Year Return | 22.59 % |
| Market Stats | |
| Previous Close | ₹2,327.40 |
| Open | ₹2,324.00 |
| Volume | 3.53L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹19,428.64Cr |
Analyst Rating for Dr Lal Pathlabs Ltd stock
based on 19 analysts
Based on 19 analysts offering long term price targets for Dr Lal Pathlabs Ltd. An average target of ₹2450.11
Source: S&P Global Market Intelligence
Company Information
The company's top products include pathology tests, imaging tests, and preventive health check-ups. Its popular brands include Dr Lal PathLabs, Lal PathLabs, and Lal PathLabs Diagnostics. Dr Lal PathLabs Ltd has over 2000 labs across India, with more than 2000 collection centers, and over 20000 trained professionals. The company is also present in Nepal, Sri Lanka, and Bangladesh.
Dr Lal PathLabs Ltd is committed to providing quality healthcare services and products to its customers. It is ISO 9001:2015 certified and has been accredited by the National Accreditation Board for Testing and Calibration Laboratories (NABL).
Share Price: ₹2244.60 per share as on 18 Apr, 2024 04:01 PM
Market Capitalisation: ₹19,428.64Cr as of today
Revenue: ₹538.90Cr as on December 2023 (Q4 23)
Net Profit: ₹82.20Cr as on December 2023 (Q4 23)
Listing date: 23 Dec, 2015
Chairperson Name: Arvind Lal
| Organisation | Dr Lal Pathlabs Ltd |
| Headquarters | Gurgaon |
| Industry | Healthcare |
| E-voting on shares | Click here to vote |
Key events for Dr Lal Pathlabs Ltd
Dr Lal Pathlabs ROCE Falls to 22% - 13 Apr, 2024
Dr. Lal PathLabs has an ROCE of 22%, outpacing the industry average but down from 29% five years ago. While reinvesting for growth, it may take time before earnings improve. The stock has delivered a 130% gain over five years.
Dr Lal Pathlabs Stock Gains Over 3% - 12 Apr, 2024
Dr Lal Pathlabs Ltd's stock gained over 3% to reach Rs.2,381.80 with a significant increase in trading volume on the BSE.
Diagnostic Companies to Register 10-11% Growth in Revenue by FY2025 - 10 Apr, 2024
A study by CRISIL predicts that diagnostic companies, including Dr Lal PathLabs, are set to register a growth of 10-11% in revenue by financial year 2025 due to an increase in patients and improving revenue per patient.
BNP Paribas Gives Buy Call on Dr Lal Pathlabs with Target Price of Rs 3181 - 05 Apr, 2024
BNP Paribas has given a buy call on Dr Lal Pathlabs with a target price of Rs 3181. The company reported a consolidated total income of Rs 557.20 crore for the quarter ended December 31, 2023, and net profit after tax of Rs 82.20 crore. Promoters hold 54.6% stake in the company.
Dr Lal PathLabs Upgraded by Kotak Institutional Equities - 26 Mar, 2024
Kotak Institutional Equities has double upgraded Dr Lal PathLabs from Sell to Add with an increased fair value of ₹2,360. The revised price target implies a potential upside of 8% from last Friday's closing levels.
Insiders Own More Than Half of Dr. Lal PathLabs Ltd - 23 Mar, 2024
Insiders own over 50% of Dr. Lal PathLabs, with shares worth ₹100b in the ₹177b company, indicating strong alignment with shareholders.
UBS Maintains Buy Rating on Dr Lal PathLabs - 22 Mar, 2024
UBS has maintained a buy rating on Dr Lal PathLabs with a target price of Rs 2900. The company's rising cash pile and profitability could be deployed for future investment, aided by operating leverage. Marginal price increases have been observed on digital platforms in the past six months.
Shankha Banerjee Named New CEO of Dr Lal Pathlabs - 18 Mar, 2024
Dr Lal PathLabs has appointed Shankha Banerjee as its new Chief Executive Officer (CEO) and Key Managerial Personnel, effective May 21, 2024. Banerjee brings over two decades of corporate experience to the role, having held key positions at Castrol India Limited, BP Lubricants, and Pidilite Industries Limited.
Fundamentals of Dr Lal Pathlabs Ltd
Insights on Dr Lal Pathlabs Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTMF Holding Up
Mutual Funds have increased holdings from 5.36% to 5.88% in Dec 2023 quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 24.36% to 25.35% in Dec 2023 quarter
NO EFFECTAgainst Peers
In the last 3 years, Max Healthcare Institute Ltd has given 250.2% return, outperforming this stock by 272.5%
- NO EFFECT
Against Peers
In the last 1 year, Global Health Ltd has given 182.1% return, outperforming this stock by 159.5%
NEGATIVE IMPACTPromoter Holding Down
Promoters have decreased holdings from 54.61% to 54.60% in Dec 2023 quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 619.4 Cr → 557.2 Cr (in ₹), with an average decrease of 10.0% per quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 109.3 Cr → 81.3 Cr (in ₹), with an average decrease of 25.6% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 3 years, LALPATHLAB stock has moved down by -22.4%
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 11.48% to 10.12% in Dec 2023 quarter
Dr Lal Pathlabs Ltd Valuation
Dr Lal Pathlabs Ltd in the last 5 years
Lowest (37.51x)
November 16, 2018
Today (58.60x)
April 16, 2024
Industry (94.07x)
April 16, 2024
Highest (95.62x)
November 5, 2020
Mutual Fund Holdings
| Funds | Holdings |
 UTI Flexi Cap Fund - Growth Option - Direct | 1.49% |
 SBI Large & Midcap Fund Direct Growth | 0.69% |
| UTI Mid Cap Fund-Growth Option- Direct | 1.21% |
 PGIM India Midcap Opportunities Fund Direct Growth | 0.89% |
 Kotak Equity Arbitrage Fund Direct Growth | 0.18% |
Shareholding Pattern
| Investors | Holdings % | Prev. 4 periods | 3M change |
|---|---|---|---|
| Promoter Holdings | 54.6% | ||
| Foreign Institutions | 25.35% | 4.09 | |
| Mutual Funds | 5.88% | 9.74 | |
| Retail Investors | 10.12% | ||
| Others | 4.05% |
Technicals of Dr Lal Pathlabs Ltd share
News & Events of Dr Lal Pathlabs Ltd
Frequently Asked Questions
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Dr Lal Pathlabs Ltd shares.
Dr Lal Pathlabs Ltd (LALPATHLAB) share price today is ₹2244.6
Dr Lal Pathlabs Ltd is listed on NSE
Dr Lal Pathlabs Ltd is listed on BSE
- Today’s highest price of Dr Lal Pathlabs Ltd is ₹2327.
- Today’s lowest price of Dr Lal Pathlabs Ltd is ₹2235.
PE Ratio of Dr Lal Pathlabs Ltd is 58.6
PE ratio = Dr Lal Pathlabs Ltd Market price per share / Dr Lal Pathlabs Ltd Earnings per share
Today’s traded volume of Dr Lal Pathlabs Ltd(LALPATHLAB) is 3.53L.
Today’s market capitalisation of Dr Lal Pathlabs Ltd(LALPATHLAB) is ₹19428.64Cr.
| Dr Lal Pathlabs Ltd(LALPATHLAB | Price |
|---|---|
52 Week High | ₹2767.1 |
52 Week Low | ₹1872.55 |
Dr Lal Pathlabs Ltd(LALPATHLAB) share price is ₹2244.6. It is down -18.88% from its 52 Week High price of ₹2767.1
Dr Lal Pathlabs Ltd(LALPATHLAB) share price is ₹2244.6. It is up 19.87% from its 52 Week Low price of ₹1872.55
| Dr Lal Pathlabs Ltd(LALPATHLAB | Returns |
|---|---|
1 Day Returns | -82.8% |
1 Month Returns | 15.71% |
3 Month Returns | -5.23% |
1 Year Returns | 22.59% |